Our Board is led by biotech industry veteran and non-executive director, Dr Colin Dalton and further comprises two executive directors, Dave Ahern and James Tibbatts, and non-executive director Stijn Van Rompay.
We’re proud to have assembled a loyal team of world-class scientists, engineers, and designers, as well as human factors, quality, and regulatory experts. Together, we have over 150 FTE years of Combination Product development experience.
We recognise that our staff and associates are our most important assets, and we are committed to continuous investment in training and professional development.
We have also formed scientific and commercial advisory panels including industry experts from companies such as Vectura and GSK.